ArticleESMO gastrointestinal oncology2026
Tumor response to neoadjuvant treatment as a predictor of benefit for adjuvant treatment in esophago-gastric cancers: a systematic review and meta-analysis.
S M Jinnaah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.